EE516 Budget-Impact Model of Adalimumab-Biosimilar Sandoz in the Management of Autoimmune Diseases in the Middle East
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.758
https://www.valueinhealthjournal.com/article/S1098-3015(22)02962-X/fulltext
Title :
EE516 Budget-Impact Model of Adalimumab-Biosimilar Sandoz in the Management of Autoimmune Diseases in the Middle East
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02962-X&doi=10.1016/j.jval.2022.09.758
First page :
Section Title :
Open access? :
No
Section Order :
10300